Cargando…
Enzyme Inhibitors: The Best Strategy to Tackle Superbug NDM-1 and Its Variants
Multidrug bacterial resistance endangers clinically effective antimicrobial therapy and continues to cause major public health problems, which have been upgraded to unprecedented levels in recent years, worldwide. β-Lactam antibiotics have become an important weapon to fight against pathogen infecti...
Autores principales: | Li, Xiaoting, Zhao, Dongmei, Li, Weina, Sun, Jichao, Zhang, Xiuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745225/ https://www.ncbi.nlm.nih.gov/pubmed/35008622 http://dx.doi.org/10.3390/ijms23010197 |
Ejemplares similares
-
Superbug – the so-called NDM-1
por: Srivastava, R.K., et al.
Publicado: (2011) -
Betaxolol as a Potent Inhibitor of NDM-1-Positive E. coli That Synergistically Enhances the Anti-Inflammatory Effect in Combination with Meropenem
por: Sun, Jichao, et al.
Publicado: (2023) -
Indigenous Oral and Gut Phages Defeat the Deadly NDM-1 Superbug
por: Yadalam, Pradeep Kumar, et al.
Publicado: (2023) -
Sorting out the Superbugs: Potential of Sortase A Inhibitors among Other Antimicrobial Strategies to Tackle the Problem of Antibiotic Resistance
por: Zrelovs, Nikita, et al.
Publicado: (2021) -
Novel temporin L antimicrobial peptides: promoting self-assembling by lipidic tags to tackle superbugs
por: Bellavita, Rosa, et al.
Publicado: (2020)